Tag:

immatics

Latest Headlines

Latest Headlines

Germany's immatics bags $30M for cancer vaccine trial

July 17, 2014 | By
Though the cancer vaccine field has seen more setbacks than successes, some companies are forging ahead with ambitious plans to push their therapeutics toward regulatory approval.
Related Tags
Press Releases
  • Alvogen Launches the First Generic Exelon® Patch in the United States
  • First U.S. Patient Treated With Revolutionary Automatic Brain Metastases Planning Software by Brainlab
  • Bioline Launches New EPIK miRNA Panel Assays
  • Presbia to Complete Second Stage Enrollment in the US FDA Pivotal Study of Presbia Flexivue Microlens
  • Thoratec Announces Start Of Shield II™ U.S. Clinical Trial
  • More Press Releases
Sponsored Links